Study Name:
CASCADE-LUNG (Cancer Screening Assay using DELFI): A Clinical Validation Study in Lung Cancer

Targeted Disease(s):
Lung Cancer

Purpose of Study:

We are recruiting approximately 15,000 individuals for a large-scale study to help determine the ability of our simple, blood-based screening technology to detect lung cancer accurately and reliably.

Study Dates:
August 1, 2022 - September 30, 2023

Study Location:

Lead Institution:
Thomas Jefferson University

Funding Source:
Delfi Diagnostics


Registration phone: 855-457-4816
Registration email: [email protected] Identifier:

Register for Trial
Freedom From Smoking Clinic - Richmond, VA
Richmond, VA | Sep 03, 2024
COPD Educator Course
, | Oct 17, 2024